Defining Dosimetric Reference Levels in Computed Tomography Spectral Scanning (NR Spectral)

December 12, 2025 updated by: Centre Hospitalier Universitaire de Nīmes

Spectral computed tomography or dual-energy CT imaging can overcome the limitations of conventional CT in differentiating between two materials with equivalent total attenuation. It can generate several types of images, such as virtual monochromatic images, which improve the contrast-to-noise ratio for low energy levels and reduce artifacts for high energy levels. It also allows for quantitative image analysis and thus better characterization of lesions and tissues through material mapping (e.g., iodinated contrast agent mapping). This technique is increasingly used in routine clinical practice thanks to improvements in image flow management and technological advances. It also involves exposing patients to ionizing radiation, as with conventional CT but, unlike conventional CT scans, for which dosimetric reference levels (RLs) are defined for the most common examinations in France (RL decree dated 2019), there are currently no dosimetric reference levels for examinations performed using this technique. Yet RLs are an important and effective tools for optimizing patient exposure to ionizing radiation. Several articles were published between 2012 and 2017 when the first dual-energy scanners arrived in clinics. However, the results presented in these studies are now far removed from recent practices, as they do not take into account the latest technological developments used in dual-energy scanners, which reduce X-ray doses.

The main objective of the study is to define dosimetric reference levels for the most commonly performed spectral computed tomography examinations in France.

Study Overview

Status

Active, not recruiting

Conditions

Detailed Description

Spectral computed tomography (CT) (or dual-energy CT) imaging can overcome the limitations of conventional CT in differentiating between two materials with equivalent total attenuation. It can generate several types of images, such as virtual monochromatic images, which improve the contrast-to-noise ratio for low energy levels and reduce artifacts for high energy levels. It also allows for quantitative image analysis and thus better characterization of lesions and tissues through material mapping (e.g., iodinated contrast agent mapping). This technique is increasingly used in routine clinical practice thanks to improvements in image flow management and technological advances. It also involves exposing patients to ionizing radiation, as with conventional CT.

However, unlike conventional CT scans, for which dosimetric reference levels (RLs) are defined for the most common examinations in France (RL decree dated 2019), there are currently no dosimetric reference levels for examinations performed using this technique. Yet the RL is an important and effective tool in optimizing patient exposure to ionizing radiation. In fact, a number of articles were published between 2012 and 2017, when the first dual-energy scanners arrived in clinics. However, the results presented in these studies are now far removed from recent practices, as they do not take into account the latest technological developments used in dual-energy scanners, which reduce X-ray doses.

The main objective of the study is to define dosimetric reference levels for the most frequently performed spectral computed tomography examinations in France:

  1. Chest CT for pulmonary embolism
  2. Chest CT for other indications
  3. Coronary CT with contrast injection and retrospective gating
  4. Coronary CT with contrast injection and prospective gating
  5. Cranial CT with contrast injection
  6. Supra-aortic trunk CT
  7. Neck and ear,nose and throat sphere CT with contrast injection
  8. Oncological abdomen-pelvis CT scan
  9. Abdomen-pelvis CT scan to check for kidney stones
  10. Abdomen-pelvis CT scan for non-oncological purposes and to check for kidney stones
  11. Oncological chest-abdomen-pelvis CT scan
  12. Non-oncological chest-abdomen-pelvis CT scan
  13. Oncological chest-abdomen CT scan
  14. Non-oncological chest-abdomen CT scan
  15. Lower limb angiography
  16. Cervical spine CT scan
  17. Thoracic spine CT scan
  18. Lumbar spine CT scan
  19. Pelvis CT scan,
  20. Extremities CT scan

The secondary objectives of the study are to evaluate, for each examination performed:

  1. the impact of the spectral acquisition/detection technique on the dose delivered to patients.
  2. the impact of patients' BMI on the dose delivered to patients.
  3. the impact of reconstruction algorithms on the dose delivered to patients.

Study Type

Observational

Enrollment (Actual)

9600

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Gard
      • Nîmes, Gard, France, 30029
        • Nimes University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

All adult patients who underwent a spectral CT scan between January 1, 2023, and August 31, 2024, as part of their treatment.

Description

Inclusion Criteria:

  • Adult male/female patient (≥ 18 years old)
  • Body Mass Index (BMI) between 18 and 35 kg/m²
  • Patients who underwent a spectral CT scan between January 1, 2023, and August 31, 2024, as part of their treatment.

Exclusion Criteria:

- Pregnant women

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Patients undergoing a maximum number of 18 spectral CT scans among the examinations mentioned below

Patients undergoing a maximum number of 18 spectral CT scans among the examinations mentioned below:

  1. Chest CT for pulmonary embolism
  2. Chest CT for other indications
  3. Coronary CT with contrast injection and retrospective gating
  4. Coronary CT with contrast injection and prospective gating
  5. Cranial CT with contrast injection
  6. Supra-aortic trunk CT
  7. Neck and ear,nose and throat sphere CT with contrast injection
  8. Oncological abdomen-pelvis CT scan
  9. Abdomen-pelvis CT scan to check for kidney stones
  10. Abdomen-pelvis CT scan for non-oncological purposes and to check for kidney stones
  11. Oncological chest-abdomen-pelvis CT scan
  12. Non-oncological chest-abdomen-pelvis CT scan
  13. Oncological chest-abdomen CT scan
  14. Non-oncological chest-abdomen CT scan
  15. Lower limb angiography
  16. Cervical spine CT scan
  17. Thoracic spine CT scan
  18. Lumbar spine CT scan
  19. Pelvis CT scan,
  20. Extremities CT scan
Commonly performed spectral computed tomography examinations in France

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Dosimetric reference levels for spectral computed tomography examinations in France: Chest CT for pulmonary embolism. CTDIvol
Time Frame: Periprocedural
Computed tomography dose index (CTDIvol) per acquisition expressed in milligray (mGy).
Periprocedural
Dosimetric reference levels for spectral computed tomography examinations in France: Chest CT for pulmonary embolism. DLP
Time Frame: Periprocedural
Dose length product (DLP) expressed in mGy.cm
Periprocedural
Dosimetric reference levels for spectral computed tomography examinations in France: Chest CT for other indications. CTDIvol
Time Frame: Periprocedural
Computed tomography dose index (CTDIvol) per acquisition expressed in milligray (mGy).
Periprocedural
Dosimetric reference levels for spectral computed tomography examinations in France: Chest CT for other indications. DLP
Time Frame: Periprocedural
Dose length product (DLP) expressed in mGy.cm
Periprocedural
Dosimetric reference levels for spectral computed tomography examinations in France: Coronary CT with contrast injection and retrospective gating. CTDIvol
Time Frame: Periprocedural
Computed tomography dose index (CTDIvol) per acquisition expressed in milligray (mGy).
Periprocedural
Dosimetric reference levels for spectral computed tomography examinations in France: Coronary CT with contrast injection and prospective gating. DLP
Time Frame: Periprocedural
Dose length product (DLP) expressed in mGy.cm
Periprocedural
Dosimetric reference levels for spectral computed tomography examinations in France: Cranial CT with contrast injection. CTDIvol
Time Frame: Periprocedural
Computed tomography dose index (CTDIvol) per acquisition expressed in milligray (mGy).
Periprocedural
Dosimetric reference levels for spectral computed tomography examinations in France: Cranial CT with contrast injection. DLP
Time Frame: Periprocedural
Dose length product (DLP) expressed in mGy.cm
Periprocedural
Dosimetric reference levels for spectral computed tomography examinations in France: Supra-aortic trunk CT. CTDIvol
Time Frame: Periprocedural
Computed tomography dose index (CTDIvol) per acquisition expressed in milligray (mGy).
Periprocedural
Dosimetric reference levels for spectral computed tomography examinations in France: Supra-aortic trunk CT. DLP
Time Frame: Periprocedural
Dose length product (DLP) expressed in mGy.cm
Periprocedural
Dosimetric reference levels for spectral computed tomography examinations in France: Neck and ear,nose and throat sphere CT with contrast injection. CTDIvol
Time Frame: Periprocedural
Computed tomography dose index (CTDIvol) per acquisition expressed in milligray (mGy).
Periprocedural
Dosimetric reference levels for spectral computed tomography examinations in France: Neck and ear,nose and throat sphere CT with contrast injection. DLP
Time Frame: Periprocedural
Dose length product (DLP) expressed in mGy.cm
Periprocedural
Dosimetric reference levels for spectral computed tomography examinations in France: Oncological abdomen-pelvis CT scan. CTDIvol
Time Frame: Periprocedural
Computed tomography dose index (CTDIvol) per acquisition expressed in milligray (mGy).
Periprocedural
Dosimetric reference levels for spectral computed tomography examinations in France: Oncological abdomen-pelvis CT scan. DLP
Time Frame: Periprocedural
Dose length product (DLP) expressed in mGy.cm
Periprocedural
Dosimetric reference levels for spectral computed tomography examinations in France: Abdomen-pelvis CT scan to check for kidney stones. CTDIvol
Time Frame: Periprocedural
Computed tomography dose index (CTDIvol) per acquisition expressed in milligray (mGy).
Periprocedural
Dosimetric reference levels for spectral computed tomography examinations in France: Abdomen-pelvis CT scan to check for kidney stones. DLP
Time Frame: Periprocedural
Dose length product (DLP) expressed in mGy.cm
Periprocedural
Dosimetric reference levels for spectral computed tomography examinations in France: Abdomen-pelvis CT scan for non-oncological purposes and to check for kidney stones. CTDIvol
Time Frame: Periprocedural
Computed tomography dose index (CTDIvol) per acquisition expressed in milligray (mGy).
Periprocedural
Dosimetric reference levels for spectral computed tomography examinations in France: Abdomen-pelvis CT scan for non-oncological purposes and to check for kidney stones. DLP
Time Frame: Periprocedural
Dose length product (DLP) expressed in mGy.cm
Periprocedural
Dosimetric reference levels for spectral computed tomography examinations in France: Oncological chest-abdomen-pelvis CT scan. CTDIvol
Time Frame: Periprocedural
Computed tomography dose index (CTDIvol) per acquisition expressed in milligray (mGy).
Periprocedural
Dosimetric reference levels for spectral computed tomography examinations in France: Oncological chest-abdomen-pelvis CT scan. DLP
Time Frame: Periprocedural
Dose length product (DLP) expressed in mGy.cm
Periprocedural
Dosimetric reference levels for spectral computed tomography examinations in France: Non-oncological chest-abdomen-pelvis CT scan. CTDIvol
Time Frame: Periprocedural
Computed tomography dose index (CTDIvol) per acquisition expressed in milligray (mGy).
Periprocedural
Dosimetric reference levels for spectral computed tomography examinations in France: Non-oncological chest-abdomen-pelvis CT scan. DLP
Time Frame: Periprocedural
Dose length product (DLP) expressed in mGy.cm
Periprocedural
Dosimetric reference levels for spectral computed tomography examinations in France: Oncological chest-abdomen CT scan. CTDIvol
Time Frame: Periprocedural
Computed tomography dose index (CTDIvol) per acquisition expressed in milligray (mGy).
Periprocedural
Dosimetric reference levels for spectral computed tomography examinations in France: Oncological chest-abdomen CT scan. DLP
Time Frame: Periprocedural
Dose length product (DLP) expressed in mGy.cm
Periprocedural
Dosimetric reference levels for spectral computed tomography examinations in France: Non-oncological chest-abdomen CT scan. CTDIvol
Time Frame: Periprocedural
Computed tomography dose index (CTDIvol) per acquisition expressed in milligray (mGy).
Periprocedural
Dosimetric reference levels for spectral computed tomography examinations in France: Non-oncological chest-abdomen CT scan. DLP
Time Frame: Periprocedural
Dose length product (DLP) expressed in mGy.cm
Periprocedural
Dosimetric reference levels for spectral computed tomography examinations in France: Lower limb angiography. CTDIvol
Time Frame: Periprocedural
Computed tomography dose index (CTDIvol) per acquisition expressed in milligray (mGy).
Periprocedural
Dosimetric reference levels for spectral computed tomography examinations in France: Lower limb angiography. DLP
Time Frame: Periprocedural
Dose length product (DLP) expressed in mGy.cm
Periprocedural
Dosimetric reference levels for spectral computed tomography examinations in France: Cervical spine CT scan. CTDIvol
Time Frame: Periprocedural
Computed tomography dose index (CTDIvol) per acquisition expressed in milligray (mGy).
Periprocedural
Dosimetric reference levels for spectral computed tomography examinations in France: Cervical spine CT scan. DLP
Time Frame: Periprocedural
Dose length product (DLP) expressed in mGy.cm
Periprocedural
Dosimetric reference levels for spectral computed tomography examinations in France: Thoracic spine CT scan. CTDIvol
Time Frame: Periprocedural
Computed tomography dose index (CTDIvol) per acquisition expressed in milligray (mGy).
Periprocedural
Dosimetric reference levels for spectral computed tomography examinations in France: Thoracic spine CT scan. DLP
Time Frame: Periprocedural
Dose length product (DLP) expressed in mGy.cm
Periprocedural
Dosimetric reference levels for spectral computed tomography examinations in France: Lumbar spine CT scan. CTDIvol
Time Frame: Periprocedural
Computed tomography dose index (CTDIvol) per acquisition expressed in milligray (mGy).
Periprocedural
Dosimetric reference levels for spectral computed tomography examinations in France: Lumbar spine CT scan. DLP
Time Frame: Periprocedural
Dose length product (DLP) expressed in mGy.cm
Periprocedural
Dosimetric reference levels for spectral computed tomography examinations in France: Pelvis CT scan. CTDIvol
Time Frame: Periprocedural
Computed tomography dose index (CTDIvol) per acquisition expressed in milligray (mGy).
Periprocedural
Dosimetric reference levels for spectral computed tomography examinations in France: Pelvis CT scan. DLP
Time Frame: Periprocedural
Dose length product (DLP) expressed in mGy.cm
Periprocedural
Dosimetric reference levels for spectral computed tomography examinations in France: Extremities CT scan. CTDIvol
Time Frame: Periprocedural
Computed tomography dose index (CTDIvol) per acquisition expressed in milligray (mGy).
Periprocedural
Dosimetric reference levels for spectral computed tomography examinations in France: Extremities CT scan. DLP
Time Frame: Periprocedural
Dose length product (DLP) expressed in mGy.cm will be recorded
Periprocedural

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Impact of the spectral acquisition/detection technique on the dose delivered to patients: Chest CT for pulmonary embolism. Acquisition type
Time Frame: Periprocedural
The type of acquisition will be recorded.
Periprocedural
Impact of the spectral acquisition/detection technique on the dose delivered to patients: Chest CT for pulmonary embolism. Number of acquisitions
Time Frame: Periprocedural
The number of acquisitions will be recorded.
Periprocedural
Impact of the spectral acquisition/detection technique on the dose delivered to patients: Chest CT for pulmonary embolism. CTDIvol
Time Frame: Periprocedural
The dose (CTDIvol) will be recorded.
Periprocedural
Impact of the spectral acquisition/detection technique on the dose delivered to patients: Chest CT for pulmonary embolism. DLP
Time Frame: Periprocedural
Dose length product (DLP) expressed in mGy.cm will be recorded.
Periprocedural
Impact of patients' BMI on the dose delivered to patients: Chest CT for pulmonary embolism. BMI
Time Frame: Periprocedural
Weight and height will be combined to report BMI in kg/m^2
Periprocedural
Impact of patients' BMI on the dose delivered to patients: Chest CT for pulmonary embolism. Acquisition parameters, kV
Time Frame: Periprocedural
Acquisition parameters (kV) will be recorded
Periprocedural
Impact of patients' BMI on the dose delivered to patients: Chest CT for pulmonary embolism. Acquisition parameters, mAs
Time Frame: Periprocedural
Acquisition parameters (mAs) will be recorded
Periprocedural
Impact of patients' BMI on the dose delivered to patients: Chest CT for pulmonary embolism. Acquisition parameters. Rotation time
Time Frame: Periprocedural
Rotation time will be recorded in seconds
Periprocedural
Impact of patients' BMI on the dose delivered to patients: Chest CT for pulmonary embolism. Acquisition parameters. Helical pitch
Time Frame: Periprocedural
Helical pitch will be recorded as a ratio. This represents the relationship between patient couch movement and X-ray beam width. It is the distance travelled by the table during one 360 degree gantry rotation divided by the collimated section thickness
Periprocedural
Impact of reconstruction algorithms on the dose delivered to patients : Chest CT for pulmonary embolism. Type of reconstruction algorithm
Time Frame: Periprocedural
The type of reconstruction algorithm (iterative or deep learning) will be recorded
Periprocedural
Impact of the spectral acquisition/detection technique on the dose delivered to patients: Chest CT for other indications. Acquisition type
Time Frame: Periprocedural
The type of acquisition will be recorded.
Periprocedural
Impact of the spectral acquisition/detection technique on the dose delivered to patients: Chest CT for other indications. Number of acquisitions
Time Frame: Periprocedural
The number of acquisitions will be recorded.
Periprocedural
Impact of the spectral acquisition/detection technique on the dose delivered to patients: Chest CT for other indications. CTDIvol
Time Frame: Periprocedural
The dose (CTDIvol) will be recorded.
Periprocedural
Impact of the spectral acquisition/detection technique on the dose delivered to patients: Chest CT for other indications. DLP
Time Frame: Periprocedural
The dose length product (DLP) expressed in mGy.cm will be recorded.
Periprocedural
Impact of patients' BMI on the dose delivered to patients: Chest CT for other indications. BMI
Time Frame: Periprocedural
Weight and height will be combined to report BMI in kg/m^2
Periprocedural
Impact of patients' BMI on the dose delivered to patients: Chest CT for other indications. Acquisition parameters, kV
Time Frame: Periprocedural
Acquisition parameters (kV) will be recorded
Periprocedural
Impact of patients' BMI on the dose delivered to patients: Chest CT for other indications. Acquisition parameters, mAs
Time Frame: Periprocedural
Acquisition parameters (mAs) will be recorded
Periprocedural
Impact of patients' BMI on the dose delivered to patients: Chest CT for other indications. Acquisition parameters, rotation time
Time Frame: Periprocedural
Rotation time will be recorded in seconds
Periprocedural
Impact of patients' BMI on the dose delivered to patients: Chest CT for other indications. Acquisition parameters, helical pitch
Time Frame: Periprocedural
Helical pitch time will be recorded as a ratio. This represents the relationship between patient couch movement and X-ray beam width. It is the distance travelled by the table during one 360 degree gantry rotation divided by the collimated section thickness
Periprocedural
Impact of reconstruction algorithms on the dose delivered to patients : Chest CT for other indications. Type of reconstruction algorithm
Time Frame: Periprocedural
The type of reconstruction algorithm (iterative or deep learning) will be recorded
Periprocedural
Impact of the spectral acquisition/detection technique on the dose delivered to patients: Coronary CT with contrast injection and retrospective gating. Acquisition type
Time Frame: Periprocedural
The type of acquisition will be recorded.
Periprocedural
Impact of the spectral acquisition/detection technique on the dose delivered to patients: Coronary CT with contrast injection and retrospective gating. Number of acquisitions
Time Frame: Periprocedural
The number of acquisitions will be recorded.
Periprocedural
Impact of the spectral acquisition/detection technique on the dose delivered to patients: Coronary CT with contrast injection and retrospective gating. CTDIvol
Time Frame: Periprocedural
The dose (CTDIvol) will be recorded.
Periprocedural
Impact of the spectral acquisition/detection technique on the dose delivered to patients: Coronary CT with contrast injection and retrospective gating. DLP
Time Frame: Periprocedural
The dose length product (DLP) will be recorded.
Periprocedural
Impact of patients' BMI on the dose delivered to patients : Coronary CT with contrast injection and retrospective gating. BMI
Time Frame: Periprocedural
Weight and height will be combined to report BMI in kg/m^2
Periprocedural
Impact of patients' BMI on the dose delivered to patients : Coronary CT with contrast injection and retrospective gating. Acquisition parameters, kV
Time Frame: Periprocedural
Acquisition parameters (kV) will be recorded
Periprocedural
Impact of patients' BMI on the dose delivered to patients : Coronary CT with contrast injection and retrospective gating. Acquisition parameters, mAs
Time Frame: Periprocedural
Acquisition parameters (mAs) will be recorded
Periprocedural
Impact of patients' BMI on the dose delivered to patients : Coronary CT with contrast injection and retrospective gating. Rotation time
Time Frame: Periprocedural
Rotation time will be recorded in seconds
Periprocedural
Impact of patients' BMI on the dose delivered to patients : Coronary CT with contrast injection and retrospective gating. Helical pitch
Time Frame: Periprocedural
Helical pitch will be recorded as a ratio. This represents the relationship between patient couch movement and X-ray beam width. It is the distance travelled by the table during one 360 degree gantry rotation divided by the collimated section thickness
Periprocedural
Impact of reconstruction algorithms on the dose delivered to patients : Coronary CT with contrast injection and retrospective gating. Type of reconstruction algorithm
Time Frame: Periprocedural
The type of reconstruction algorithm (iterative or deep learning) will be recorded
Periprocedural
Impact of the spectral acquisition/detection technique on the dose delivered to patients: Cranial CT with contrast injection. Acquisition type
Time Frame: Periprocedural
The type of acquisition will be recorded.
Periprocedural
Impact of the spectral acquisition/detection technique on the dose delivered to patients: Cranial CT with contrast injection. Number of acquisitions
Time Frame: Periprocedural
The number of acquisitions will be recorded.
Periprocedural
Impact of the spectral acquisition/detection technique on the dose delivered to patients: Cranial CT with contrast injection. CTDIvol
Time Frame: Periprocedural
The dose (CTDIvol) will be recorded.
Periprocedural
Impact of the spectral acquisition/detection technique on the dose delivered to patients: Cranial CT with contrast injection. DLP
Time Frame: Periprocedural
Dose length product (DLP) will be recorded.
Periprocedural
Impact of patients' BMI on the dose delivered to patients: Cranial CT with contrast injection. BMI
Time Frame: Periprocedural
Weight and height will be combined to report BMI in kg/m^2
Periprocedural
Impact of patients' BMI on the dose delivered to patients: Cranial CT with contrast injection. Acquisition parameters, kV
Time Frame: Periprocedural
Acquisition parameters (kV)will be recorded
Periprocedural
Impact of patients' BMI on the dose delivered to patients: Cranial CT with contrast injection. Acquisition parameters, mAs
Time Frame: Periprocedural
Acquisition parameters (mAs) will be recorded
Periprocedural
Impact of patients' BMI on the dose delivered to patients: Cranial CT with contrast injection. Rotation time
Time Frame: Periprocedural
Rotation time will be recorded in seconds
Periprocedural
Impact of patients' BMI on the dose delivered to patients: Cranial CT with contrast injection. Helical pitch
Time Frame: Periprocedural
Helical pitch will be recorded as a ratio. This represents the relationship between patient couch movement and X-ray beam width. It is the distance travelled by the table during one 360 degree gantry rotation divided by the collimated section thickness
Periprocedural
Impact of reconstruction algorithms on the dose delivered to patients : Cranial CT with contrast injection. Type of reconstruction algorithm
Time Frame: Periprocedural
The type of reconstruction algorithm (iterative or deep learning) will be recorded
Periprocedural
Impact of the spectral acquisition/detection technique on the dose delivered to patients: Supra-aortic trunk CT. Acquisition type
Time Frame: Periprocedural
The type of acquisition will be recorded
Periprocedural
Impact of the spectral acquisition/detection technique on the dose delivered to patients: Supra-aortic trunk CT. Number of acquisitions
Time Frame: Periprocedural
The number of acquisitions will be recorded
Periprocedural
Impact of the spectral acquisition/detection technique on the dose delivered to patients: Supra-aortic trunk CT. CTDIvol
Time Frame: Periprocedural
The dose (CTDIvol) will be recorded.
Periprocedural
Impact of the spectral acquisition/detection technique on the dose delivered to patients: Supra-aortic trunk CT. DLP
Time Frame: Periprocedural
The dose (DLP) expressed in mGy.cm will be recorded.
Periprocedural
Impact of patients' BMI on the dose delivered to patients : Supra-aortic trunk CT. BMI
Time Frame: Periprocedural
Weight and height will be combined to report BMI in kg/m^2
Periprocedural
Impact of patients' BMI on the dose delivered to patients : Supra-aortic trunk CT. Acquisition parameters. kV
Time Frame: Periprocedural
Acquisition parameters (kV) will be recorded
Periprocedural
Impact of patients' BMI on the dose delivered to patients : Supra-aortic trunk CT. Acquisition parameters. mAs
Time Frame: Periprocedural
Acquisition parameters (mAs) will be recorded
Periprocedural
Impact of patients' BMI on the dose delivered to patients : Supra-aortic trunk CT. Acquisition parameters. Rotation time
Time Frame: Periprocedural
Rotation time will be recorded in seconds
Periprocedural
Impact of patients' BMI on the dose delivered to patients : Supra-aortic trunk CT. Acquisition parameters. Helical pitch
Time Frame: Periprocedural
Helical pitch will be recorded as a ratio. This represents the relationship between patient couch movement and X-ray beam width. It is the distance travelled by the table during one 360 degree gantry rotation divided by the collimated section thickness
Periprocedural
Impact of the spectral acquisition/detection technique on the dose delivered to patients: Neck and ear, nose and throat sphere CT with contrast injection. Acquisition type
Time Frame: Periprocedural
The type of acquisition will be recorded.
Periprocedural
Impact of the spectral acquisition/detection technique on the dose delivered to patients: Neck and ear, nose and throat sphere CT with contrast injection. Number of acquisitions
Time Frame: Periprocedural
The number of acquisitions will be recorded.
Periprocedural
Impact of the spectral acquisition/detection technique on the dose delivered to patients: Neck and ear, nose and throat sphere CT with contrast injection. CTDIvol
Time Frame: Periprocedural
The dose (CTDIvol) will be recorded.
Periprocedural
Impact of the spectral acquisition/detection technique on the dose delivered to patients: Neck and ear, nose and throat sphere CT with contrast injection. DLP
Time Frame: Periprocedural
The dose (DLP) expressed in mGy.cm will be recorded
Periprocedural
Impact of patients' BMI on the dose delivered to patients : Neck and ear, nose and throat sphere CT with contrast injection. BMI
Time Frame: Periprocedural
Weight and height will be combined to report BMI in kg/m^2
Periprocedural
Impact of reconstruction algorithms on the dose delivered to patients : Neck and ear, nose and throat sphere CT with contrast injection. Type of reconstruction algorithm
Time Frame: Periprocedural
The type of reconstruction algorithm (iterative or deep learning) will be recorded
Periprocedural
Impact of the spectral acquisition/detection technique on the dose delivered to patients: Oncological abdomen-pelvis CT scan. Acquisition type
Time Frame: Periprocedural
The type of acquisitions will be recorded.
Periprocedural
Impact of the spectral acquisition/detection technique on the dose delivered to patients: Oncological abdomen-pelvis CT scan. Number of acquisitions
Time Frame: Periprocedural
The number of acquisitions will be recorded.
Periprocedural
Impact of the spectral acquisition/detection technique on the dose delivered to patients: Oncological abdomen-pelvis CT scan. CTDIvol
Time Frame: Periprocedural
The dose (CDTIvol) will be recorded.
Periprocedural
Impact of the spectral acquisition/detection technique on the dose delivered to patients: Oncological abdomen-pelvis CT scan. DLP
Time Frame: Periprocedural
The dose length product (DLP) expressed in mGy.cm will be recorded
Periprocedural
Impact of patients' BMI on the dose delivered to patients : Oncological abdomen-pelvis CT scan. BMI
Time Frame: Periprocedural
Weight and height will be combined to report BMI in kg/m^2
Periprocedural
Impact of patients' BMI on the dose delivered to patients : Oncological abdomen-pelvis CT scan. Acquisition parameters (kV)
Time Frame: Periprocedural
Acquisition parameters (kV) will be recorded
Periprocedural
Impact of patients' BMI on the dose delivered to patients : Oncological abdomen-pelvis CT scan. Acquisition parameters (mAs)
Time Frame: Periprocedural
Acquisition parameters (mAs) will be recorded
Periprocedural
Impact of patients' BMI on the dose delivered to patients : Oncological abdomen-pelvis CT scan. Acquisition parameters. Rotation time
Time Frame: Periprocedural
Rotation time will be recorded in seconds
Periprocedural
Impact of patients' BMI on the dose delivered to patients : Oncological abdomen-pelvis CT scan. Acquisition parameters. Helical pitch
Time Frame: Periprocedural
Helical pitch will be recorded will be recorded as a ratio. This represents the relationship between patient couch movement and X-ray beam width. It is the distance travelled by the table during one 360 degree gantry rotation divided by the collimated section thickness
Periprocedural
Impact of reconstruction algorithms on the dose delivered to patients: Oncological abdomen-pelvis CT scan. Type of reconstruction algorithm
Time Frame: Periprocedural
The type of reconstruction algorithm (iterative or deep learning) will be recorded
Periprocedural
Impact of the spectral acquisition/detection technique on the dose delivered to patients: Abdomen-pelvis CT scan to check for kidney stones. Acquisition type an
Time Frame: Periprocedural
The type of acquisition will be recorded.
Periprocedural
Impact of the spectral acquisition/detection technique on the dose delivered to patients: Abdomen-pelvis CT scan to check for kidney stones. Number of acquisitions an
Time Frame: Periprocedural
The number of acquisitions will be recorded.
Periprocedural
Impact of the spectral acquisition/detection technique on the dose delivered to patients: Abdomen-pelvis CT scan to check for kidney stones. CTDIvol an
Time Frame: Periprocedural
The dose (CDTIvol) will be recorded.
Periprocedural
Impact of the spectral acquisition/detection technique on the dose delivered to patients: Abdomen-pelvis CT scan to check for kidney stones. DLP an
Time Frame: Periprocedural
The dose length product (DLP) expressed in mGy.cm will be recorded.
Periprocedural
Impact of patients' BMI on the dose delivered to patients : Abdomen-pelvis CT scan to check for kidney stones. BMI an
Time Frame: Periprocedural
Weight and height will be combined to report BMI in kg/m^2
Periprocedural
Impact of patients' BMI on the dose delivered to patients : Abdomen-pelvis CT scan to check for kidney stones. Acquisition parameters. Kv an
Time Frame: Periprocedural
Acquisition parameters (kV) will be recorded
Periprocedural
Impact of patients' BMI on the dose delivered to patients : Abdomen-pelvis CT scan to check for kidney stones. Acquisition parameters. mAs an
Time Frame: Periprocedural
Acquisition parameters (mAs) will be recorded
Periprocedural
Impact of patients' BMI on the dose delivered to patients : Abdomen-pelvis CT scan to check for kidney stones. Rotation time an
Time Frame: Periprocedural
Rotation time will be recorded in seconds
Periprocedural
Impact of patients' BMI on the dose delivered to patients : Abdomen-pelvis CT scan to check for kidney stones. Helical pitch an
Time Frame: Periprocedural
Helical pitch will be recorded as a ratio. This represents the relationship between patient couch movement and X-ray beam width. It is the distance travelled by the table during one 360 degree gantry rotation divided by the collimated section thickness
Periprocedural
Impact of reconstruction algorithms on the dose delivered to patients : Abdomen-pelvis CT scan to check for kidney stones. Type of reconstruction algorithm an
Time Frame: Periprocedural
The type of reconstruction algorithm (iterative or deep learning) will be recorded
Periprocedural
Impact of the spectral acquisition/detection technique on the dose delivered to patients: Abdomen-pelvis CT scan for non-oncological purposes and to check for kidney stones. Acquisition type
Time Frame: Periprocedural
The type of acquisition will be recorded.
Periprocedural
Impact of the spectral acquisition/detection technique on the dose delivered to patients: Abdomen-pelvis CT scan for non-oncological purposes and to check for kidney stones. Number of acquisitions
Time Frame: Periprocedural
The number of acquisitions will be recorded.
Periprocedural
Impact of the spectral acquisition/detection technique on the dose delivered to patients: Abdomen-pelvis CT scan for non-oncological purposes and to check for kidney stones. CTDIvol
Time Frame: Periprocedural
The dose (CTDIvol) will be recorded.
Periprocedural
Impact of the spectral acquisition/detection technique on the dose delivered to patients: Abdomen-pelvis CT scan for non-oncological purposes and to check for kidney stones. DLP
Time Frame: Periprocedural
The dose length product (DLP) expressed in mGy.cm will be recorded.
Periprocedural
Impact of patients' BMI on the dose delivered to patients : Abdomen-pelvis CT scan for non-oncological purposes and to check for kidney stones. BMI
Time Frame: Periprocedural
Weight and height will be combined to report BMI in kg/m^2
Periprocedural
Impact of patients' BMI on the dose delivered to patients : Abdomen-pelvis CT scan for non-oncological purposes and to check for kidney stones. Acquisition parameters. kV
Time Frame: Periprocedural
Acquisition parameters (kV) will be recorded
Periprocedural
Impact of patients' BMI on the dose delivered to patients : Abdomen-pelvis CT scan for non-oncological purposes and to check for kidney stones. Acquisition parameters. mAs
Time Frame: Periprocedural
Acquisition parameters (mAs) will be recorded
Periprocedural
Impact of patients' BMI on the dose delivered to patients : Abdomen-pelvis CT scan for non-oncological purposes and to check for kidney stones. Rotation time
Time Frame: Periprocedural
Rotation time will be recorded in seconds
Periprocedural
Impact of patients' BMI on the dose delivered to patients : Abdomen-pelvis CT scan for non-oncological purposes and to check for kidney stones. Helical pitch
Time Frame: Periprocedural
Helical pitch will be recorded as a ratio. This represents the relationship between patient couch movement and X-ray beam width. It is the distance travelled by the table during one 360 degree gantry rotation divided by the collimated section thickness
Periprocedural
Impact of reconstruction algorithms on the dose delivered to patients : Abdomen-pelvis CT scan for non-oncological purposes and to check for kidney stones. Type of reconstruction algorithm
Time Frame: Periprocedural
The type of reconstruction algorithm (iterative or deep learning) will be recorded
Periprocedural
Impact of the spectral acquisition/detection technique on the dose delivered to patients: Oncological chest-abdomen-pelvis CT scan. Acquisition type
Time Frame: Periprocedural
The type of acquisition will be recorded.
Periprocedural
Impact of the spectral acquisition/detection technique on the dose delivered to patients: Oncological chest-abdomen-pelvis CT scan. Number of acquisitions
Time Frame: Periprocedural
The number of acquisitions will be recorded.
Periprocedural
Impact of the spectral acquisition/detection technique on the dose delivered to patients: Oncological chest-abdomen-pelvis CT scan. CTDIvol
Time Frame: Periprocedural
The dose (CDTIvol) will be recorded.
Periprocedural
Impact of the spectral acquisition/detection technique on the dose delivered to patients: Oncological chest-abdomen-pelvis CT scan. DLP
Time Frame: Periprocedural
The dose (DLP) expressed in mGy.cm will be recorded.
Periprocedural
Impact of patients' BMI on the dose delivered to patients : Oncological chest-abdomen-pelvis CT scan. BMI
Time Frame: Periprocedural
Weight and height will be combined to report BMI in kg/m^2
Periprocedural
Impact of patients' BMI on the dose delivered to patients : Oncological chest-abdomen-pelvis CT scan. Acquisition parameters. kV
Time Frame: Periprocedural
Acquisition parameters (kV) will be recorded
Periprocedural
Impact of patients' BMI on the dose delivered to patients : Oncological chest-abdomen-pelvis CT scan. Acquisition parameters. mAs
Time Frame: Periprocedural
Acquisition parameters (mAs) will be recorded
Periprocedural
Impact of patients' BMI on the dose delivered to patients : Oncological chest-abdomen-pelvis CT scan. Rotation time
Time Frame: Periprocedural
Rotation time will be recorded in seconds
Periprocedural
Impact of patients' BMI on the dose delivered to patients : Oncological chest-abdomen-pelvis CT scan. Helical pitch
Time Frame: Periprocedural
Helical pitch will be recorded as a ratio. This represents the relationship between patient couch movement and X-ray beam width. It is the distance travelled by the table during one 360 degree gantry rotation divided by the collimated section thickness
Periprocedural
Impact of reconstruction algorithms on the dose delivered to patients : Oncological chest-abdomen-pelvis CT scan. Type of reconstruction algorithm
Time Frame: Periprocedural
The type of reconstruction algorithm (iterative or deep learning) will be recorded
Periprocedural
Impact of the spectral acquisition/detection technique on the dose delivered to patients: Non-oncological chest-abdomen-pelvis CT scan. Acquisition type.
Time Frame: Periprocedural
The type of acquisition will be recorded.
Periprocedural
Impact of the spectral acquisition/detection technique on the dose delivered to patients: Non-oncological chest-abdomen-pelvis CT scan. Number of acquisitions.
Time Frame: Periprocedural
The number of acquisitions will be recorded.
Periprocedural
Impact of the spectral acquisition/detection technique on the dose delivered to patients: Non-oncological chest-abdomen-pelvis CT scan. CDTIvol
Time Frame: Periprocedural
The dose (CTDIvol) will be recorded.
Periprocedural
Impact of the spectral acquisition/detection technique on the dose delivered to patients: Non-oncological chest-abdomen-pelvis CT scan. CDTIvol. DLP
Time Frame: Periprocedural
The dose length product (DLP) expressed in mGy.cm will be recorded.
Periprocedural
Impact of patients' BMI on the dose delivered to patients : Non-oncological chest-abdomen-pelvis CT scan. BMI
Time Frame: Periprocedural
Weight and height will be combined to report BMI in kg/m^2
Periprocedural
Impact of patients' BMI on the dose delivered to patients : Non-oncological chest-abdomen-pelvis CT scan. Acquisition parameters. kV
Time Frame: Periprocedural
Acquisition parameters (kV) will be recorded
Periprocedural
Impact of patients' BMI on the dose delivered to patients : Non-oncological chest-abdomen-pelvis CT scan. Acquisition parameters. mAs
Time Frame: Periprocedural
Acquisition parameters (mAs) will be recorded
Periprocedural
Impact of patients' BMI on the dose delivered to patients : Non-oncological chest-abdomen-pelvis CT scan. Acquisition parameters. Rotation time
Time Frame: Periprocedural
Rotation time will be recorded in seconds
Periprocedural
Impact of patients' BMI on the dose delivered to patients : Non-oncological chest-abdomen-pelvis CT scan. Acquisition parameters. Helical pitch
Time Frame: Periprocedural
Helical pitch will be recorded as a ratio. This represents the relationship between patient couch movement and X-ray beam width. It is the distance travelled by the table during one 360 degree gantry rotation divided by the collimated section thickness
Periprocedural
Impact of reconstruction algorithms on the dose delivered to patients : Non-oncological chest-abdomen-pelvis CT scan. Type of reconstruction algorithm
Time Frame: Periprocedural
The type of reconstruction algorithm (iterative or deep learning) will be recorded
Periprocedural
Impact of the spectral acquisition/detection technique on the dose delivered to patients: Oncological chest-abdomen CT scan. Aquisition type
Time Frame: Periprocedural
The type of acquisitions will be recorded.
Periprocedural
Impact of the spectral acquisition/detection technique on the dose delivered to patients: Oncological chest-abdomen CT scan. Number of aquisitions
Time Frame: Periprocedural
The number of acquisitions will be recorded.
Periprocedural
Impact of the spectral acquisition/detection technique on the dose delivered to patients: Oncological chest-abdomen CT scan. CTDIvol
Time Frame: Periprocedural
The dose (CTDIvol) will be recorded.
Periprocedural
Impact of the spectral acquisition/detection technique on the dose delivered to patients: Oncological chest-abdomen CT scan. DLP
Time Frame: Periprocedural
The dose length product (DLP) expressed in mGy.cm will be recorded.
Periprocedural
Impact of patients' BMI on the dose delivered to patients : Oncological chest-abdomen CT scan. BMI
Time Frame: Periprocedural
Weight and height will be combined to report BMI in kg/m^2
Periprocedural
Impact of patients' BMI on the dose delivered to patients : Oncological chest-abdomen CT scan. Acquisition parameters (kV)
Time Frame: Periprocedural
Acquisition parameters (kV) will be recorded
Periprocedural
Impact of patients' BMI on the dose delivered to patients : Oncological chest-abdomen CT scan. Acquisition parameters (mAs)
Time Frame: Periprocedural
Acquisition parameters (mAs) will be recorded
Periprocedural
Impact of patients' BMI on the dose delivered to patients : Oncological chest-abdomen CT scan. Rotation time
Time Frame: Periprocedural
Rotation time will be recorded in seconds
Periprocedural
Impact of patients' BMI on the dose delivered to patients : Oncological chest-abdomen CT scan. Helical pitch
Time Frame: Periprocedural
Helical pitch will be recorded as a ratio. This represents the relationship between patient couch movement and X-ray beam width. It is the distance travelled by the table during one 360 degree gantry rotation divided by the collimated section thickness
Periprocedural
Impact of reconstruction algorithms on the dose delivered to patients : Oncological chest-abdomen CT scan. Type of reconstruction algorithm
Time Frame: Periprocedural
The type of reconstruction algorithm (iterative or deep learning) will be recorded
Periprocedural
Impact of the spectral acquisition/detection technique on the dose delivered to patients: Non-oncological chest-abdomen CT scan. Acquisition type
Time Frame: Periprocedural
The type of acquisition will be recorded.
Periprocedural
Impact of the spectral acquisition/detection technique on the dose delivered to patients: Non-oncological chest-abdomen CT scan. Number of acquisitions
Time Frame: Periprocedural
The number of acquisitions will be recorded.
Periprocedural
Impact of the spectral acquisition/detection technique on the dose delivered to patients: Non-oncological chest-abdomen CT scan. CTDIvol
Time Frame: Periprocedural
The dose (CDTIvol) will be recorded.
Periprocedural
Impact of the spectral acquisition/detection technique on the dose delivered to patients: Non-oncological chest-abdomen CT scan. DLP
Time Frame: Periprocedural
The dose length product (DLP) expressed in mGy.cm will be recorded.
Periprocedural
Impact of patients' BMI on the dose delivered to patients : Non-oncological chest-abdomen CT scan
Time Frame: Periprocedural
Weight and height will be combined to report BMI in kg/m^2
Periprocedural
Impact of patients' BMI on the dose delivered to patients : Non-oncological chest-abdomen CT scan. Acquisition parameters. kV
Time Frame: Periprocedural
Acquisition parameters (kV) will be recorded
Periprocedural
Impact of patients' BMI on the dose delivered to patients : Non-oncological chest-abdomen CT scan. Acquisition parameters. mAs
Time Frame: Periprocedural
Acquisition parameters (mAs) will be recorded
Periprocedural
Impact of reconstruction algorithms on the dose delivered to patients: Non-oncological chest-abdomen CT scan. Type of reconstruction algorithm
Time Frame: Periprocedural
The type of reconstruction algorithm (iterative or deep learning) will be recorded
Periprocedural
Impact of the spectral acquisition/detection technique on the dose delivered to patients: Lower limb angiography. Acquisition type
Time Frame: Periprocedural
The type of acquisition will be recorded.
Periprocedural
Impact of the spectral acquisition/detection technique on the dose delivered to patients: Lower limb angiography. Number of acquitions
Time Frame: Periprocedural
The number of acquisitions will be recorded.
Periprocedural
Impact of the spectral acquisition/detection technique on the dose delivered to patients: Lower limb angiography. CTDIvol
Time Frame: Periprocedural
The dose CDTIvol) will be recorded.
Periprocedural
Impact of the spectral acquisition/detection technique on the dose delivered to patients: Lower limb angiography. DLP
Time Frame: Periprocedural
The dose length product (DLP) expressed in mGy.cm will be recorded.
Periprocedural
Impact of patients' BMI on the dose delivered to patients : Lower limb angiography. BMI
Time Frame: Periprocedural
Weight and height will be combined to report BMI in kg/m^2
Periprocedural
Impact of patients' BMI on the dose delivered to patients : Lower limb angiography. Acquisition parameters. kV
Time Frame: Periprocedural
Acquisition parameters (kV) will be recorded
Periprocedural
Impact of patients' BMI on the dose delivered to patients : Lower limb angiography. Acquisition parameters. mAs
Time Frame: Periprocedural
Acquisition parameters (mAs) will be recorded
Periprocedural
Impact of the spectral acquisition/detection technique on the dose delivered to patients: Lower limb angiography. Rotation time
Time Frame: Periprocedural
Rotation time will be recorded in seconds.
Periprocedural
Impact of the spectral acquisition/detection technique on the dose delivered to patients: Lower limb angiography. Helical pitch
Time Frame: Periprocedural
Helical pitch will be recorded as a ratio.This represents the relationship between patient couch movement and X-ray beam width. It is the distance travelled by the table during one 360 degree gantry rotation divided by the collimated section thickness
Periprocedural
Impact of the spectral acquisition/detection technique on the dose delivered to patients: Lower limb angiography. Type of reconstruction algorithm
Time Frame: Periprocedural
Type of reconstruction algorithm (iterative or deep learning) will be recorded
Periprocedural
Impact of the spectral acquisition/detection technique on the dose delivered to patients: Cervical spine CT scan. Acquisition type
Time Frame: Periprocedural
The type of acquisition will be recorded.
Periprocedural
Impact of the spectral acquisition/detection technique on the dose delivered to patients: Cervical spine CT scan. Number of acquisitions
Time Frame: Periprocedural
The number of acquisitions will be recorded.
Periprocedural
Impact of the spectral acquisition/detection technique on the dose delivered to patients: Cervical spine CT scan. CDTIvol
Time Frame: Periprocedural
The dose (CDTIvol) will be recorded.
Periprocedural
Impact of the spectral acquisition/detection technique on the dose delivered to patients: Cervical spine CT scan. DLP
Time Frame: Periprocedural
The dose length product (DLP) expressed in mGy.cm will be recorded.
Periprocedural
Impact of patients' BMI on the dose delivered to patients : Cervical spine CT scan. BMI
Time Frame: Periprocedural
Weight and height will be combined to report BMI in kg/m^2
Periprocedural
Impact of patients' BMI on the dose delivered to patients : Cervical spine CT scan. Acquisition parameters. kV
Time Frame: Periprocedural
Acquisition parameters (kV) will be recorded
Periprocedural
Impact of patients' BMI on the dose delivered to patients : Cervical spine CT scan. Acquisition parameters. mAs
Time Frame: Periprocedural
Acquisition parameters (mAs) will be recorded
Periprocedural
Impact of patients' BMI on the dose delivered to patients : Cervical spine CT scan. Acquisition parameters. Rotation time
Time Frame: Periprocedural
Rotation time will be recorded in seconds
Periprocedural
Impact of patients' BMI on the dose delivered to patients : Cervical spine CT scan. Acquisition parameters. Helical pitch
Time Frame: Periprocedural
Helical pitch will be recorded as a ratio. This represents the relationship between patient couch movement and X-ray beam width. It is the distance travelled by the table during one 360 degree gantry rotation divided by the collimated section thickness
Periprocedural
Impact of reconstruction algorithms on the dose delivered to patients : Cervical spine CT scan. Type of reconstruction algorithm
Time Frame: Periprocedural
The type of reconstruction algorithm (iterative or deep learning) will be recorded
Periprocedural
Impact of the spectral acquisition/detection technique on the dose delivered to patients: Thoracic spine CT scan. Acquisition type
Time Frame: Periprocedural
The type of acquisition will be recorded.
Periprocedural
Impact of the spectral acquisition/detection technique on the dose delivered to patients: Thoracic spine CT scan. Number of acquisitions
Time Frame: Periprocedural
The number of acquisition will be recorded.
Periprocedural
Impact of the spectral acquisition/detection technique on the dose delivered to patients: Thoracic spine CT scan. CTDIvol
Time Frame: Periprocedural
The dose (CDTIvol) will be recorded.
Periprocedural
Impact of the spectral acquisition/detection technique on the dose delivered to patients: Thoracic spine CT scan. DLP
Time Frame: Periprocedural
The dose length product (DLP) expressed in mGy.cm will be recorded.
Periprocedural
Impact of patients' BMI on the dose delivered to patients : Thoracic spine CT scan. BMI
Time Frame: Periprocedural
Weight and height will be combined to report BMI in kg/m^2
Periprocedural
Impact of patients' BMI on the dose delivered to patients : Thoracic spine CT scan. Acquisition parameters (kV)
Time Frame: Periprocedural
Acquisition parameters (kV) will be recorded
Periprocedural
Impact of patients' BMI on the dose delivered to patients : Thoracic spine CT scan. Acquisition parameters (mAs)
Time Frame: Periprocedural
Acquisition parameters (mAs) will be recorded
Periprocedural
Impact of patients' BMI on the dose delivered to patients : Thoracic spine CT scan. Rotation time
Time Frame: Periprocedural
Rotation time will be recorded in seconds
Periprocedural
Impact of patients' BMI on the dose delivered to patients : Thoracic spine CT scan. Helical pitch
Time Frame: Periprocedural
Helical pitch will be recorded as a ratio. This represents the relationship between patient couch movement and X-ray beam width. It is the distance travelled by the table during one 360 degree gantry rotation divided by the collimated section thickness
Periprocedural
Impact of reconstruction algorithms on the dose delivered to patients : Thoracic spine CT scan. Type of reconstruction algorithm
Time Frame: Periprocedural
The type of reconstruction algorithm (iterative or deep learning) will be recorded
Periprocedural
Impact of the spectral acquisition/detection technique on the dose delivered to patients: Lumbar spine CT scan. Acquisition type
Time Frame: Periprocedural
The type of acquisition will be recorded.
Periprocedural
Impact of the spectral acquisition/detection technique on the dose delivered to patients: Lumbar spine CT scan. Number of acquisitions
Time Frame: Periprocedural
The number of acquisition will be recorded.
Periprocedural
Impact of the spectral acquisition/detection technique on the dose delivered to patients: Lumbar spine CT scan. CTDIvol
Time Frame: Periprocedural
The dose (CDTIvol) will be recorded.
Periprocedural
Impact of the spectral acquisition/detection technique on the dose delivered to patients: Lumbar spine CT scan. DLP
Time Frame: Periprocedural
The dose length product (DLP) expressed in mGy.cm will be recorded
Periprocedural
Impact of patients' BMI on the dose delivered to patients : Lumbar spine CT scan. BMI
Time Frame: Periprocedural
Weight and height will be combined to report BMI in kg/m^2
Periprocedural
Impact of patients' BMI on the dose delivered to patients : Lumbar spine CT scan. Acquisition parameters. kV
Time Frame: Periprocedural
Acquisition parameters (kV) will be recorded
Periprocedural
Impact of patients' BMI on the dose delivered to patients : Lumbar spine CT scan. Acquisition parameters. mAs
Time Frame: Periprocedural
Acquisition parameters (mAs) will be recorded
Periprocedural
Impact of patients' BMI on the dose delivered to patients : Lumbar spine CT scan. Acquisition parameters. Rotation time
Time Frame: Periprocedural
Rotation time will be recorded in seconds
Periprocedural
Impact of patients' BMI on the dose delivered to patients : Lumbar spine CT scan. Acquisition parameters. Helical pitch
Time Frame: Periprocedural
Helical pitch will be recorded as a ratio. This represents the relationship between patient couch movement and X-ray beam width. It is the distance travelled by the table during one 360 degree gantry rotation divided by the collimated section thickness
Periprocedural
Impact of reconstruction algorithms on the dose delivered to patients: Lumbar spine CT scan. Type of reconstruction algorithm
Time Frame: Periprocedural
The type of reconstruction algorithm (iterative or deep learning) will be recorded
Periprocedural
Impact of the spectral acquisition/detection technique on the dose delivered to patients: Pelvis CT scan. Acquisition type
Time Frame: Periprocedural
The type of acquisition will be recorded.
Periprocedural
Impact of the spectral acquisition/detection technique on the dose delivered to patients: Pelvis CT scan. Number of acquisitions
Time Frame: Periprocedural
The number of acquisitions will be recorded.
Periprocedural
Impact of the spectral acquisition/detection technique on the dose delivered to patients: Pelvis CT scan. CTDIvol
Time Frame: Periprocedural
The dose (CDTIvol) will be recorded.
Periprocedural
Impact of the spectral acquisition/detection technique on the dose delivered to patients: Pelvis CT scan. DLP
Time Frame: Periprocedural
The dose length product (DLP) expressed in mGy.cm will be recorded.
Periprocedural
Impact of patients' BMI on the dose delivered to patients : Pelvis CT scan. BMI.
Time Frame: Periprocedural
Weight and height will be combined to report BMI in kg/m^2
Periprocedural
Impact of patients' BMI on the dose delivered to patients : Pelvis CT scan. Acquistion parameters. kV
Time Frame: Periprocedural
Acquisition parameters (kV) will be recorded
Periprocedural
Impact of patients' BMI on the dose delivered to patients : Pelvis CT scan. Acquistion parameters. mAs
Time Frame: Periprocedural
Acquisition parameters (mAs) will be recorded
Periprocedural
Impact of patients' BMI on the dose delivered to patients : Pelvis CT scan. Acquistion parameters. Rotation time
Time Frame: Periprocedural
Rotation time will be recorded in seconds
Periprocedural
Impact of patients' BMI on the dose delivered to patients : Pelvis CT scan. Acquistion parameters. Helical pitch
Time Frame: Periprocedural
Helical pitch will be recorded as a ratio. This represents the relationship between patient couch movement and X-ray beam width. It is the distance travelled by the table during one 360 degree gantry rotation divided by the collimated section thickness
Periprocedural
Impact of reconstruction algorithms on the dose delivered to patients : Pelvis CT scan. Type of reconstruction algorithm
Time Frame: Periprocedural
The type of reconstruction algorithm (iterative or deep learning) will be recorded
Periprocedural
Impact of the spectral acquisition/detection technique on the dose delivered to patients: Extremities CT scan. Acquisition type
Time Frame: Periprocedural
The type of acquisition will be recorded.
Periprocedural
Impact of the spectral acquisition/detection technique on the dose delivered to patients: Extremities CT scan. Number of acquisitions
Time Frame: Periprocedural
The number of acquisitions will be recorded.
Periprocedural
Impact of the spectral acquisition/detection technique on the dose delivered to patients: Extremities CT scan. CTDIvol
Time Frame: Periprocedural
The dose (CTDIvol) will be recorded.
Periprocedural
Impact of the spectral acquisition/detection technique on the dose delivered to patients: Extremities CT scan. DLP
Time Frame: Periprocedural
The dose length product (DLP) expressed in mGy.cm will be recorded
Periprocedural
Impact of patients' BMI on the dose delivered to patients : Extremities CT scan. BMI
Time Frame: Periprocedural
Weight in kg and height in cm in will be combined to report BMI in kg/m^2
Periprocedural
Impact of patients' BMI on the dose delivered to patients : Extremities CT scan. Acquisition parameters. kV
Time Frame: Periprocedural
Acquisition parameters (kV) will be recorded
Periprocedural
Impact of patients' BMI on the dose delivered to patients : Extremities CT scan. Acquisition parameters. mAs
Time Frame: Periprocedural
Acquisition parameters (mAs) will be recorded
Periprocedural
Impact of patients' BMI on the dose delivered to patients : Extremities CT scan. Acquisition parameters. Rotation time
Time Frame: Periprocedural
Rotation time will be recorded in seconds
Periprocedural
Impact of patients' BMI on the dose delivered to patients : Extremities CT scan. Acquisition parameters. Helical pitch
Time Frame: Periprocedural
Helical pitch will be recorded as a ratio. This represents the relationship between patient couch movement and X-ray beam width. It is the distance travelled by the table during one 360 degree gantry rotation divided by the collimated section thickness
Periprocedural
Impact of reconstruction algorithms on the dose delivered to patients: Extremities CT scan. Type of reconstruction algorithm
Time Frame: Periprocedural
The type of reconstruction algorithm (iterative or deep learning) will be recorded
Periprocedural

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2025

Primary Completion (Estimated)

December 31, 2025

Study Completion (Estimated)

June 30, 2026

Study Registration Dates

First Submitted

September 10, 2025

First Submitted That Met QC Criteria

December 12, 2025

First Posted (Actual)

December 26, 2025

Study Record Updates

Last Update Posted (Actual)

December 26, 2025

Last Update Submitted That Met QC Criteria

December 12, 2025

Last Verified

November 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • NIMAO/2024-1/DD-01

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Medical Imaging

Clinical Trials on Spectral ComputedTomography

Subscribe